Drug developer 9 Meters Biopharma files for bankruptcy protection
July 18 (Reuters) - 9 Meters Biopharma NMTR.O said the drug developer and its unit have filed for Chapter 11 bankruptcy protection, according to a regulatory filing on Tuesday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection